News from chimerix, inc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Mar 28, 2013, 07:00 ET Chimerix's Antiviral CMX001 Abstract Selected for an Oral Presentation at the European Group for Blood and Marrow Transplantation's Annual Meeting

Chimerix, Inc., a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced presentations...


Mar 14, 2013, 07:00 ET Chimerix Appoints Michael D. Rogers, Ph.D., as Chief Development Officer

 Chimerix, Inc., a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, announced today that...


Mar 12, 2013, 07:00 ET FDA Grants Chimerix Fast Track Designation for CMX001 for the Prevention of Clinically Significant Cytomegalovirus Infection

 Chimerix, Inc., a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced that the...


Mar 08, 2013, 17:10 ET Chimerix Files Registration Statement for Proposed Initial Public Offering

Chimerix, Inc., a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced that it has...


Feb 20, 2013, 07:00 ET Ernest Mario, Ph.D., Named Chairman of Chimerix, Inc.

Chimerix, Inc., a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced the appointment...


Feb 19, 2013, 07:00 ET Data Demonstrating the Safety and Efficacy of Chimerix's Antiviral CMX001 Presented at BMT Tandem Meetings

 Chimerix, Inc., a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today released data from...


Feb 04, 2013, 07:00 ET Data Related to Chimerix's Antiviral CMX001 to be Presented in Three Poster Sessions at the BMT Tandem Meetings

 Chimerix, Inc., a biopharmaceutical company developing antivirals in areas of high unmet medical need, today announced that three abstracts...


Nov 26, 2012, 07:00 ET Chimerix To Present At Therapeutic Area Partnerships Meeting

 Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, today announced that President and Chief Executive...


Nov 12, 2012, 09:00 ET Chimerix Appoints Michelle Berrey Chief Medical Officer

Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, announced today that Michelle Berrey, MD, MPH, has...


Nov 12, 2012, 07:00 ET Chimerix To Present At Two Upcoming Healthcare Conferences In November

Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, today announced presentations at two upcoming investor...


Sep 21, 2012, 12:56 ET Chimerix Presents Data Highlighting Burden Of Care Associated With Current Antiviral Therapies In Stem Cell Transplantation

Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, today announced data highlighting the significant...


Jul 24, 2012, 07:30 ET Chimerix Signs Worldwide License Agreement With Merck For CMX157, A Novel Candidate For The Treatment Of HIV

 Chimerix, Inc. today announced the execution of a license agreement granting Merck, known as MSD outside the United States and Canada,...


Jul 23, 2012, 10:37 ET Chimerix's Broad Spectrum Antiviral Therapeutic, CMX001, Demonstrates Potential To Mitigate BK Virus Associated End-Organ Disease In Clinical Study

 Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, today announced the presentation of data showing...


Jul 09, 2012, 10:00 ET Chimerix Announces BK Virus Data In Late-Breaking Poster Session At The 24th International Congress Of The Transplantation Society

Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, today announced a late-breaking poster presentation at...


Apr 03, 2012, 10:00 ET Chimerix to Present at Upcoming Needham and Future Leaders Conferences

Chimerix, Inc., a biotechnology company developing novel antiviral therapeutics, today announced presentations at two upcoming investor conferences...


Mar 05, 2012, 10:00 ET Chimerix to Present at Cowen and Company's 32nd Annual Health Care Conference

 Chimerix, Inc., a biotechnology company developing novel antiviral therapeutics, today announced that Kenneth I. Moch, President and Chief...


Feb 06, 2012, 08:30 ET Chimerix Antiviral Compound, CMX001, Meets CMV Phase 2 Primary Endpoint in Allogeneic Hematopoietic Stem Cell Transplant Recipients

 Chimerix, Inc., a biotechnology company developing novel antiviral therapeutics, today announced positive results from CMX001 Study 201, a...


Jan 25, 2012, 12:00 ET Chimerix Announces Presentation of Final Data from CMX001 Phase 2 Trial in Prophylaxis of Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients

Chimerix, Inc., a biotechnology company developing novel antiviral therapeutics, today announced that final data from CMX001 Study 201, a...


Nov 11, 2011, 12:06 ET Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting

Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, today announced a late-breaking poster presentation at...


Nov 09, 2011, 10:00 ET Chimerix to Present at Upcoming Lazard and Piper Jaffray Healthcare Conferences

Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, today announced that Kenneth I. Moch, President and...


Nov 07, 2011, 10:30 ET Chimerix Honored With "2011 Southeast BIO Deal of the Year: Venture Capital Transaction" Award

Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, was presented with the "2011 SEBIO Deal of the Year:...


Sep 16, 2011, 11:00 ET Chimerix Announces Late-Breaker Presentation at 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Annual Meeting

Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, announced today that investigators will present...


Sep 06, 2011, 11:00 ET Chimerix to Present at Stifel Nicolaus 2011 Healthcare Conference

Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, today announced that Kenneth I. Moch, President and...


Jul 20, 2011, 10:13 ET Chimerix to Present at Infocast's 9th Annual Biodefense Vaccines & Therapeutics Conference

Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, announced today that George Painter, Ph.D., Chairman of...


Jul 13, 2011, 10:00 ET Chimerix Commences Phase 2 Clinical Study of CMX001 for Prevention of Adenovirus Disease in Pediatric and Adult Hematopoietic Stem Cell Transplant Patients

Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, today announced that patient dosing has begun in the...